Details of the Drug Reposition

General Information of This Drug (ID: DMD9WSC)

Drug Name
Memantine   DMD9WSC
Synonyms Memantine ER; Namenda XR; Memantine (extended release); Memantine (extended release), Forest
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Asperger syndrome DIS7IBSP N.A. Approved [1]
Glioblastoma DISI0V5E 2A00 Approved [1]
Alzheimer disease DISF8S70 8A20 Approved [2]
------------------------------------------------------------------------------------
1 Discontinued in Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Schizophrenia DISSRV2N 6A20 Discontinued in Phase 3 [3]
------------------------------------------------------------------------------------

References

1 Memantine FDA Label
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4253).
3 Study to Determine if a New Nicotine Replacement Therapy Can Safely Help Smokers to Quit Smoking